Acebrophylline 200 Mg Fexofenadine 120 Mg and Montelukast 10 Mg Tab,Acyclovir 400 Mg Tab,Azelnidipi
Dg Armed Forces Medical Service
Bid Publish Date
17-Mar-2025, 7:30 pm
Bid End Date
07-Apr-2025, 8:00 pm
EMD
₹290
Location
Progress
RAQuantity
86520
A tender has been published for Indian Army Nor Ethisterone 5 mg Tab, Oestrogen Conjugated 0 point 625 mg Tab, Gliclazide MR 30 mg Tab, Glipizide 5 mg Tab, Pioglitazone Hydrochloride 15 mg Tab, Carbimazole 5 mg Tab, Tab Thyroxine Sodium 12 point 5 mcg, Cap Tacrolimus 1 mg prolonged release, Cap Tacrolimus 0 point 25 mg, Carnitine 200 mg Tab, Tacrolimus 0 point 5 mg Cap, Sevelamer 400 mg Tab, Sevelamer Carbonate Sachet 800 mg, Cinnarizine 25 mg Tab, Alprazolam 0 point 25 mg Tab, Chlorpromazine HCl 100 mg Tab, Chlorpromazine 25 mg Tab, Darifenacin 15 mg Tab, Solifenacin 10 mg Tab, Silodosin 4 mg Tab, Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj, Tranexamic Acid 500 mg 5 ml Inj, Nandrolone Decanoate 25 mg ml Inj, Diltiazem 5 mg ml Inj, Labetalol HCl 5 mg ml 4 ml Inj, Atropine Sulphate 0 point 6 mg 1 ml Inj, Adrenaline Tartrate 1 each to 1000 1 ml Inj, Frusemide 20 mg 2 ml Inj, Inj Dexmedetomidine 100 mcg ml 50 ml vial, Ketamine HCl 50 mg ml 2 ml Inj, Thiopentone Inj of 0 point 5 g without water for Inj, Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl, Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic, Inj Etomidate 2 mg ml 10 ml Vial, Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj, Inj Diclofenac 75 mg ml 1 ml Amp, Dexmedetomidine 100 mcg ml Inj, Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml, Paracetamol 10 mg ml infusion in 50 ml bottle, Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone, Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml, Levetiracetam 100 mg ml Inj vial of 5 ml, Phenobarbitone Sodium 200 mg 1 ml Inj, Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed, Verapamil 5 mg 2 ml Inj, Amiodarone HCl 150 mg 3 ml Inj, Esmolol 100 mg 10 ml Inj, Metoprolol 1 mg ml 5 ml Inj, Digoxin 0 point 5 mg 2 ml Inj, Vasopressin 20 units ml Inj 1 ml ampoule, Metoclopramide HCl 5 mg ml 2 ml Inj, Dicyclomine HCl 20 mg Inj, Carboprost Tromethamine 250 mcg ml 1 ml Inj, Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj, Methylergometrine maleate 0 point 2 mg 1 ml Inj, Oxytocin 5 units per 1 point 0 ml amp Inj, Glycopyrrolate 0 point 2 mg ml 1ml Inj, Neostigmine 0 point 5 mg 1 ml Inj, Succinylchloline Chloride 50 mg ml 2 ml Inj, Vecuronium Bromide 4 mg ml 1 ml Inj, Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj, Vit B1 50 mg Inj, Vit B 12 500 mcg ml Inj, Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj, Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg, Ciprofloxacin 200 mg 100 ml Inj, Levofloxacin 500 mg in 100 ml Inj, Hepatitis B Human Immunoglobulin HBIG, Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0, Paracetamol 10 mg ml infusion in 100 ml bottle, Inj Ropivacaine 7 point 5 mg ml 10 ml Amp, Lignocaine HCl solution 2 percent for IV use 50 ml Inj, Inj mephentramine 30 mg ml of 10 ml each vial, Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml, Inj Naloxone 400 mcg ml of 1 ml amp, Inj Rocuronium 10 mg ml 10 ml Vial, Hydroxy Ethyl starch 6 percent soln bott of 500 ml, Human Rabies Immune Globulin 150 IU ml 2 ml Vial, Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses, Phytomenadione Vit K 1 mg 0 point 5 ml Inj, Hepatitis B Vaccine 10 ml in JABALPUR, MADHYA PRADESH. Quantity: 86520 by. Submission Deadline: 07-04-2025 20: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Dg Armed Forces Medical Service
Indian Army
KANNUR, KERALA
Dg Armed Forces Medical Service
KANNUR, KERALA
Indian Army
Dg Armed Forces Medical Service
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Nor Ethisterone 5 mg Tab | Nor Ethisterone 5 mg Tab | 19,500 | no | dglpproc2023 | 30 |
| 2 | Oestrogen Conjugated 0 point 625 mg Tab | Oestrogen Conjugated 0 point 625 mg Tab | 4,500 | no | dglpproc2023 | 30 |
| 3 | Gliclazide MR 30 mg Tab | Gliclazide MR 30 mg Tab | 10,000 | no | dglpproc2023 | 30 |
| 4 | Glipizide 5 mg Tab | Glipizide 5 mg Tab | 1,500 | no | dglpproc2023 | 30 |
| 5 | Pioglitazone Hydrochloride 15 mg Tab | Pioglitazone Hydrochloride 15 mg Tab | 4,200 | no | dglpproc2023 | 30 |
| 6 | Carbimazole 5 mg Tab | Carbimazole 5 mg Tab | 3,000 | no | dglpproc2023 | 30 |
| 7 | Tab Thyroxine Sodium 12 point 5 mcg | Tab Thyroxine Sodium 12 point 5 mcg | 4,500 | no | dglpproc2023 | 30 |
| 8 | Cap Tacrolimus 1 mg prolonged release | Cap Tacrolimus 1 mg prolonged release | 750 | no | dglpproc2023 | 30 |
| 9 | Cap Tacrolimus 0 point 25 mg | Cap Tacrolimus 0 point 25 mg | 300 | no | dglpproc2023 | 30 |
| 10 | Carnitine 200 mg Tab | Carnitine 200 mg Tab | 1,000 | no | dglpproc2023 | 30 |
| 11 | Tacrolimus 0 point 5 mg Cap | Tacrolimus 0 point 5 mg Cap | 1,500 | no | dglpproc2023 | 30 |
| 12 | Sevelamer 400 mg Tab | Sevelamer 400 mg Tab | 600 | no | dglpproc2023 | 30 |
| 13 | Sevelamer Carbonate Sachet 800 mg | Sevelamer Carbonate Sachet 800 mg | 60 | no | dglpproc2023 | 30 |
| 14 | Cinnarizine 25 mg Tab | Cinnarizine 25 mg Tab | 1,800 | no | dglpproc2023 | 30 |
| 15 | Alprazolam 0 point 25 mg Tab | Alprazolam 0 point 25 mg Tab | 3,000 | no | dglpproc2023 | 30 |
| 16 | Chlorpromazine HCl 100 mg Tab | Chlorpromazine HCl 100 mg Tab | 600 | no | dglpproc2023 | 30 |
| 17 | Chlorpromazine 25 mg Tab | Chlorpromazine 25 mg Tab | 600 | no | dglpproc2023 | 30 |
| 18 | Darifenacin 15 mg Tab | Darifenacin 15 mg Tab | 330 | no | dglpproc2023 | 30 |
| 19 | Solifenacin 10 mg Tab | Solifenacin 10 mg Tab | 180 | no | dglpproc2023 | 30 |
| 20 | Silodosin 4 mg Tab | Silodosin 4 mg Tab | 750 | no | dglpproc2023 | 30 |
| 21 | Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj | Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj | 600 | amp | dglpproc2023 | 30 |
| 22 | Tranexamic Acid 500 mg 5 ml Inj | Tranexamic Acid 500 mg 5 ml Inj | 1,650 | amp | dglpproc2023 | 30 |
| 23 | Nandrolone Decanoate 25 mg ml Inj | Nandrolone Decanoate 25 mg ml Inj | 30 | amp | dglpproc2023 | 30 |
| 24 | Diltiazem 5 mg ml Inj | Diltiazem 5 mg ml Inj | 30 | amp | dglpproc2023 | 30 |
| 25 | Labetalol HCl 5 mg ml 4 ml Inj | Labetalol HCl 5 mg ml 4 ml Inj | 300 | amp | dglpproc2023 | 30 |
| 26 | Atropine Sulphate 0 point 6 mg 1 ml Inj | Atropine Sulphate 0 point 6 mg 1 ml Inj | 750 | amp | dglpproc2023 | 30 |
| 27 | Adrenaline Tartrate 1 each to 1000 1 ml Inj | Adrenaline Tartrate 1 each to 1000 1 ml Inj | 1,350 | amp | dglpproc2023 | 30 |
| 28 | Frusemide 20 mg 2 ml Inj | Frusemide 20 mg 2 ml Inj | 1,200 | amp | dglpproc2023 | 30 |
| 29 | Inj Dexmedetomidine 100 mcg ml 50 ml vial | Inj Dexmedetomidine 100 mcg ml 50 ml vial | 90 | amp vial | dglpproc2023 | 30 |
| 30 | Ketamine HCl 50 mg ml 2 ml Inj | Ketamine HCl 50 mg ml 2 ml Inj | 120 | vial | dglpproc2023 | 30 |
| 31 | Thiopentone Inj of 0 point 5 g without water for Inj | Thiopentone Inj of 0 point 5 g without water for Inj | 30 | vial | dglpproc2023 | 30 |
| 32 | Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl | Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl | 45 | bott | dglpproc2023 | 30 |
| 33 | Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic | Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic | 200 | amp | dglpproc2023 | 30 |
| 34 | Inj Etomidate 2 mg ml 10 ml Vial | Inj Etomidate 2 mg ml 10 ml Vial | 30 | vial | dglpproc2023 | 30 |
| 35 | Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj | Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj | 210 | vial | dglpproc2023 | 30 |
| 36 | Inj Diclofenac 75 mg ml 1 ml Amp | Inj Diclofenac 75 mg ml 1 ml Amp | 800 | vial | dglpproc2023 | 30 |
| 37 | Dexmedetomidine 100 mcg ml Inj | Dexmedetomidine 100 mcg ml Inj | 210 | amp | dglpproc2023 | 30 |
| 38 | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml | 900 | bott | dglpproc2023 | 30 |
| 39 | Paracetamol 10 mg ml infusion in 50 ml bottle | Paracetamol 10 mg ml infusion in 50 ml bottle | 1,500 | bott | dglpproc2023 | 30 |
| 40 | Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone | Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone | 300 | vial | dglpproc2023 | 30 |
| 41 | Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml | Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml | 350 | vial | dglpproc2023 | 30 |
| 42 | Levetiracetam 100 mg ml Inj vial of 5 ml | Levetiracetam 100 mg ml Inj vial of 5 ml | 200 | vial | dglpproc2023 | 30 |
| 43 | Phenobarbitone Sodium 200 mg 1 ml Inj | Phenobarbitone Sodium 200 mg 1 ml Inj | 50 | vial | dglpproc2023 | 30 |
| 44 | Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed | Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed | 20 | pfs | dglpproc2023 | 30 |
| 45 | Verapamil 5 mg 2 ml Inj | Verapamil 5 mg 2 ml Inj | 30 | vial | dglpproc2023 | 30 |
| 46 | Amiodarone HCl 150 mg 3 ml Inj | Amiodarone HCl 150 mg 3 ml Inj | 75 | vial | dglpproc2023 | 30 |
| 47 | Esmolol 100 mg 10 ml Inj | Esmolol 100 mg 10 ml Inj | 30 | vial | dglpproc2023 | 30 |
| 48 | Metoprolol 1 mg ml 5 ml Inj | Metoprolol 1 mg ml 5 ml Inj | 75 | vial | dglpproc2023 | 30 |
| 49 | Digoxin 0 point 5 mg 2 ml Inj | Digoxin 0 point 5 mg 2 ml Inj | 45 | vial | dglpproc2023 | 30 |
| 50 | Vasopressin 20 units ml Inj 1 ml ampoule | Vasopressin 20 units ml Inj 1 ml ampoule | 125 | vial | dglpproc2023 | 30 |
| 51 | Metoclopramide HCl 5 mg ml 2 ml Inj | Metoclopramide HCl 5 mg ml 2 ml Inj | 800 | vial | dglpproc2023 | 30 |
| 52 | Dicyclomine HCl 20 mg Inj | Dicyclomine HCl 20 mg Inj | 600 | vial | dglpproc2023 | 30 |
| 53 | Carboprost Tromethamine 250 mcg ml 1 ml Inj | Carboprost Tromethamine 250 mcg ml 1 ml Inj | 228 | vial | dglpproc2023 | 30 |
| 54 | Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj | Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj | 300 | vial | dglpproc2023 | 30 |
| 55 | Methylergometrine maleate 0 point 2 mg 1 ml Inj | Methylergometrine maleate 0 point 2 mg 1 ml Inj | 300 | vial | dglpproc2023 | 30 |
| 56 | Oxytocin 5 units per 1 point 0 ml amp Inj | Oxytocin 5 units per 1 point 0 ml amp Inj | 1,500 | vial | dglpproc2023 | 30 |
| 57 | Glycopyrrolate 0 point 2 mg ml 1ml Inj | Glycopyrrolate 0 point 2 mg ml 1ml Inj | 420 | vial | dglpproc2023 | 30 |
| 58 | Neostigmine 0 point 5 mg 1 ml Inj | Neostigmine 0 point 5 mg 1 ml Inj | 390 | vial | dglpproc2023 | 30 |
| 59 | Succinylchloline Chloride 50 mg ml 2 ml Inj | Succinylchloline Chloride 50 mg ml 2 ml Inj | 30 | vial | dglpproc2023 | 30 |
| 60 | Vecuronium Bromide 4 mg ml 1 ml Inj | Vecuronium Bromide 4 mg ml 1 ml Inj | 150 | vial | dglpproc2023 | 30 |
| 61 | Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj | Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj | 300 | vial | dglpproc2023 | 30 |
| 62 | Vit B1 50 mg Inj | Vit B1 50 mg Inj | 500 | vial | dglpproc2023 | 30 |
| 63 | Vit B 12 500 mcg ml Inj | Vit B 12 500 mcg ml Inj | 1,000 | vial | dglpproc2023 | 30 |
| 64 | Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj | Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj | 250 | vial | dglpproc2023 | 30 |
| 65 | Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg | Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg | 1,200 | vial | dglpproc2023 | 30 |
| 66 | Ciprofloxacin 200 mg 100 ml Inj | Ciprofloxacin 200 mg 100 ml Inj | 1,500 | amp vial | dglpproc2023 | 30 |
| 67 | Levofloxacin 500 mg in 100 ml Inj | Levofloxacin 500 mg in 100 ml Inj | 450 | bott | dglpproc2023 | 30 |
| 68 | Hepatitis B Human Immunoglobulin HBIG | Hepatitis B Human Immunoglobulin HBIG | 6 | amp | dglpproc2023 | 30 |
| 69 | Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0 | Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0 | 150 | pfs | dglpproc2023 | 30 |
| 70 | Paracetamol 10 mg ml infusion in 100 ml bottle | Paracetamol 10 mg ml infusion in 100 ml bottle | 3,600 | bott | dglpproc2023 | 30 |
| 71 | Inj Ropivacaine 7 point 5 mg ml 10 ml Amp | Inj Ropivacaine 7 point 5 mg ml 10 ml Amp | 30 | amp | dglpproc2023 | 30 |
| 72 | Lignocaine HCl solution 2 percent for IV use 50 ml Inj | Lignocaine HCl solution 2 percent for IV use 50 ml Inj | 25 | amp vial | dglpproc2023 | 30 |
| 73 | Inj mephentramine 30 mg ml of 10 ml each vial | Inj mephentramine 30 mg ml of 10 ml each vial | 15 | vial | dglpproc2023 | 30 |
| 74 | Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml | Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml | 12 | no | dglpproc2023 | 30 |
| 75 | Inj Naloxone 400 mcg ml of 1 ml amp | Inj Naloxone 400 mcg ml of 1 ml amp | 15 | amp | dglpproc2023 | 30 |
| 76 | Inj Rocuronium 10 mg ml 10 ml Vial | Inj Rocuronium 10 mg ml 10 ml Vial | 10 | vial | dglpproc2023 | 30 |
| 77 | Hydroxy Ethyl starch 6 percent soln bott of 500 ml | Hydroxy Ethyl starch 6 percent soln bott of 500 ml | 14 | bott | dglpproc2023 | 30 |
| 78 | Human Rabies Immune Globulin 150 IU ml 2 ml Vial | Human Rabies Immune Globulin 150 IU ml 2 ml Vial | 10 | vial | dglpproc2023 | 30 |
| 79 | Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses | Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses | 900 | amp vial | dglpproc2023 | 30 |
| 80 | Phytomenadione Vit K 1 mg 0 point 5 ml Inj | Phytomenadione Vit K 1 mg 0 point 5 ml Inj | 900 | amp vial | dglpproc2023 | 30 |
| 81 | Hepatitis B Vaccine 10 ml | Hepatitis B Vaccine 10 ml | 900 | amp vial | dglpproc2023 | 30 |
Start
05-Jun-2025, 10:00 am
End
09-Jun-2025, 5:00 pm
Duration: 103 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 03-04-2025 15:57:58 | Evaluated |
| 2 | ********** Under PMA | - | 28-03-2025 16:35:50 | Evaluated |
| 3 | ********** Under PMA | - | 02-04-2025 12:58:51 | Evaluated |
| 4 | ********** Under PMA | - | 05-04-2025 15:45:45 | Evaluated |
| 5 | ********** Under PMA | - | 07-04-2025 19:29:45 | Evaluated |
| 6 | ********** Under PMA | - | 07-04-2025 18:41:29 | Evaluated |
| 7 | ********** Under PMA | - | 02-04-2025 19:15:32 | Evaluated |
| 8 | ********** Under PMA | - | 20-03-2025 17:57:47 | Evaluated |
| 9 | ********** Under PMA | - | 26-03-2025 11:05:35 | Evaluated |
| 10 | ********** Under PMA | - | 20-03-2025 10:42:50 | Evaluated |
| 11 | ********** Under PMA | - | 07-04-2025 18:35:30 | Evaluated |
| 12 | ********** Under PMA | - | 07-04-2025 16:32:41 | Evaluated |
| 13 | ********** Under PMA | - | 21-03-2025 16:40:27 | Evaluated |
| 14 | ********** Under PMA | - | 07-04-2025 17:59:07 | Evaluated |
| 15 | ********** Under PMA | - | 27-03-2025 17:28:19 | Evaluated |
| 16 | ********** Under PMA | - | 07-04-2025 19:50:44 | Evaluated |
| 17 | ********** Under PMA | - | 07-04-2025 16:09:47 | Evaluated |
Key insights about MADHYA PRADESH tender market
The eligibility requirements include being a registered entity, adherence to pharmaceutical industry regulations, and relevant experience in supplying medicine. Bidders must comply with the necessary documentation and eligibility criteria to ensure their participation.
Suppliers must ensure that all products meet stringent technical specifications and quality standards. This includes providing medications with appropriate certifications, following storage and transportation standards, and confirming compliance with pharmaceutical safety regulations.
Payment terms typically involve detailed conditions outlined in the tender documentation. Bidders should be prepared to meet specific financial requirements and provide clarity regarding their pricing strategy, ensuring transparency in the price evaluation considerations during the procurement process.
Submissions should be made electronically or physically according to the guidelines issued in the tender documentation. It’s imperative that all required documents are included and submitted in the accepted formats to facilitate a smooth evaluation and selection process.
The tender outlines specific benefits for Micro, Small, and Medium Enterprises (MSEs) to encourage their participation. Provisions may include relaxed eligibility criteria, assistance in the registration process, and potential price preferences, ultimately supporting local businesses and startups in the pharmaceutical sector.
These FAQs encompass critical aspects of the tender, providing clarity and guidance for prospective bidders. Interested parties are encouraged to thoroughly analyze the criteria and prepare their submissions accordingly.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS